Estimates of plutonium lung doses from urine bioassay are highly dependent on the rate of absorption from the lungs to blood assumed for the inhaled aerosol. Absorption occurs by dissolution of particles in lung fluid followed by uptake to blood. The latter may occur either rapidly or dissolved ions may first become temporarily bound within airway tissue. The presence of long-term binding can greatly increase lung doses, particularly if it occurs in the bronchial and bronchiolar regions. Analyses of autopsy data from Beagle dogs and USTUR Case 0269, obtained following exposure to plutonium nitrate, suggest that a small fraction of 0.2-1.1 and 0.4-0.7%, respectively, of plutonium becomes permanently bound within the lungs. The present work performs a further analysis using autopsy data of former plutonium workers of the Mayak Production Association to determine values of the bound fraction that are supported by these data. The results suggest a bound fraction value of 0-0.3%. The results also indicate that the Mayak worker population median values of the particle transport clearance parameters from the alveolar-interstitial region are largely consistent with expected values, but suggest the rate from the alveolar region to the interstitium may be lower than initially thought.
INTRODUCTION
Lung doses from inhaled plutonium aerosols are highly dependent on the rate at which deposited particulates are cleared from the lungs. Clearance occurs by two competing processes: mechanical particle transport clearance to the alimentary tract and to regional lymph nodes; and by absorption to blood. In the ICRP Publication 66, human respiratory tract model (HRTM) (1) absorption occurs by dissolution of the inhaled particulates followed by uptake to blood. The process of dissolution produces free plutonium ions, but small particulates may also be produced; those in the size range of a few nano-metres may be transferred directly to blood. Uptake to blood is assumed to be instantaneous unless the dissolved ions of the radionuclide (and possibly nanosized particulates produced by partial dissolution or deposited following inhalation) become bound within airway walls. The presence of long-term binding in the bronchial and bronchiolar airways results in a significant increase in estimated lung dose from inhaled plutonium (2) . Two analyses described in this series of publications indicate that binding of plutonium occurs the following particle dissolution:
• USTUR Case 0269. An analysis of new autopsy data from USTUR Case 0269-a worker who experienced a very high intake of plutonium nitrate by inhalation (3) . This shows that the presence of activity in the trachaeo-bronchial region at the time of death (38 years after the intake occurred) cannot be reasonably explained using the HRTM without assuming a value of f b of between 0.4 and 0.7%.
• Beagle dogs. An analysis of lung data from
Beagle dogs exposed to plutonium nitrate (4) shows that lung retention at late times (>2000 days post-exposure) cannot be reasonably explained using the HRTM without assuming a value of f b between 0.2 and 1.1%.
This work performs an analysis of 40 sets of autopsy data from Mayak Production Association (MPA) workers exposed to plutonium nitrate and oxide in order to determine:
(1) Whether the MPA worker autopsy data are also compatible with a permanent bound fraction (f b values >0). (2) If they do, then to identify values for f b that are supported by the data.
The MPA worker data are the same as those considered in the analysis of Puncher et al. (5) to determine the rate of slow dissolution in the lungs for plutonium nitrates and oxides. In common with that analysis, this work also assumes that the values of the absorption parameters, which include the bound fraction, f b , are 'shared' between workers; in other words the values are assumed to be the same for all workers and therefore described by all of the worker data. However, this study considers the measurements of plutonium in the thoracic lymph node (LNTH) and lung separately, rather than combining them in a single measurement. The results were combined in the other analysis because lung and LNTH absorption were assumed to be the same. It was decided not to combine the measurements here because it has been shown that the presence of airway tissue binding can affect the ratio of LNTH to total lung activity (6) . This analysis therefore produces posterior estimates of the parameter values for all three particle transport pathways in the alveolar-interstitial region, including the rate from the interstitium (INT) to the LNTH. Because, the particle transport rates (PTRs) are assumed to be different for each worker (unshared), the value of a particular rate for each worker is primarily only informed by the data for that worker: three data-points taken at a single time point (autopsy). Consequently, estimated values of the PTRs for each individual are likely to be very uncertain given the significant prior uncertainty on these values. Nevertheless, individual estimates of these rates can be used to assess whether the population mean (or equivalently, the median because the prior uncertainty on these values is assumed to be lognormally distributed) values for MPA workers are consistent with the assumed prior mean (or median) values.
This study uses a Bayesian approach to analyse the data. In the Bayesian framework, the state of knowledge of a model parameter value is defined as a probability distribution. This knowledge is updated by the application of Bayes' theorem and relevant measurement data:
where P(M|X) is the probability of observing the new data M, given parameter values X. The probability density function, P(X), describes the initial state of knowledge regarding X; for this reason it is referred to as the prior distribution. The updated information regarding the parameter is defined by the probability density function, P(X|M).
It represents the sum total of knowledge regarding the model parameters represented by the data and the priors. In the present context, M is a vector of the measurements of plutonium in the lungs and systemic tissues, and X is a vector of HRTM parameter values and intake. Such a Bayesian approach has been used in internal radiation protection to identify intakes in routine monitoring (7) , and estimate uncertainties on doses from bioassay data (8) (9) (10) .
METHODS

The MPA workers
The analysis used the data from 40 plutonium workers exposed to plutonium nitrates or oxides: these comprised the 20 plutonium nitrate 'test cases' and the 20 plutonium oxide cases considered by Puncher et al.
.
The data
The data for each worker consisted of three autopsy measurements:
(1) Systemic burden. Measurements of plutonium in skeleton and liver were combined to form a single 'systemic' measurement. The data were assumed to be normally distributed. Measurement uncertainties were those derived by Suslova et al. (11) and Sokolova et al. (12) The measurement uncertainty for the systemic burden was derived from the skeleton and liver uncertainty by propagation of errors, assuming that measurement uncertainties were independent between bioassay data. The analysis did not include urine bioassay for the same reasons stated by Puncher et al. (5) : mainly because it was conducted concurrently with an analysis to determine whether use of the urine data might result in biased estimates of intake and dose (13) , and so result in biased estimates of absorption parameters. However, the impact of this omission is likely to be small because Puncher et al. (5) found that the large lognormal uncertainties meant that the urine bioassay data were uninformative relative to the autopsy data and so did not affect estimates of the slow dissolution rate, s s .
Intake regimes
The intake regime was derived for each worker by superimposing the work history on the stepwise chronic intake regime described by Sokolova et al. (14) The intake pattern within each period was represented by a constant daily rate of intake (Bq d
−1
).
Biokinetic models
The models used by Puncher et al. (15) were also assumed in this analysis. All calculations were performed assuming the revised ICRP Publication 67 model (16) for plutonium published by Leggett et al. (17) and plutonium biokinetics of ICRP Publication 130 (18) . Because, the liver and skeleton measurements were combined, no adjustments were made to the model to account for alcohol-related liver disease, where appropriate. This is because the onset of liver disease appears to affect the skeleton to liver activity ratio but does not reduce the overall systemic burden compared with healthy subjects (as inferred from a comparison of lung to systemic ratios between healthy and diseased subjects, authors calculations), primarily because activity lost from the liver is redistributed to other systemic organs, principally the skeleton, rather than excreted. The revised HRTM, including reference particle transport clearance rates and breathing parameters, derived for the analysis of MPA workers under MWDS-2013 (13) , was also used in this analysis; this model is identical to the HRTM being used by ICRP in Publication 130 (18) .
Prior distributions
The prior distributions used to analyse the Mayak worker autopsy data in this analysis are the same as those assumed by Puncher et al. (3) and are summarised in Table 1 . A description of the derivation of these priors is provided by those authors. However, in addition, the present analysis included a prior distribution on the bound fraction and the rate from the INT to LNTH.
The bound fraction, f b
In order to permit only the data to inform on the posterior values, a uniform prior distribution between zero and one was assumed for the bound fraction, f b . This distribution shows no preference for one parameter value over another and its use was justified on the basis that it was assumed that there are currently no reliable estimates of f b from other studies that could form the basis of an informative prior for this parameter. (The analysis of the Beagle dog data and USTUR Case 0269 provide evidence for binding but not reliable estimates of its value, as discussed by Puncher et al. (3, 4) ).
The rate from the INT to LNTHs
A distribution, lognormal with a median value of 0.00003 d −1 and geometric standard deviation (GSD) of 3, is assumed to represent inter-subject variability for this process in humans (10) . The median value is the same as the ICRP reference value that was derived by Gregoratto et al. (19) to give a predicted LNTH to lung activity concentration ratio of 20, at a time 1 × 10 4 days post-exposure, using the HRTM. The value of 20 comes from an analysis by Kathren et al. (20) , who determined the ratio from autopsy data of former US plutonium workers (nonsmokers) exposed many years prior to death; a value of 7.8 was observed for smokers. An absolute range of <1 to 427 was observed for all 55 workers (smokers and non-smokers) exposed to 239, 240 Pu, and similar ranges were observed for workers exposed to other actinides (20) . The 95% range of ratios predicted using the prior assumed in this study is 1.4-1300, indicating that it provides more than adequate coverage of the range of possible values in the population of MPA workers.
Bayesian estimates of absorption parameters
Bayesian inference was performed in accordance with 'Calculation 2' described by Puncher et al. (5) : Markov Chain Monte Carlo (MCMC) was applied to obtain 'shared' estimates of the slow dissolution rate, s s , and bound fraction, f b , assuming that no plutonium is taken up to blood from the bound state (s b = 0), for the groups of 20 plutonium nitrate 'test' cases and 20 plutonium oxide cases considered by Puncher et al. (5) The analyses were also performed with f b fixed at zero; in other words assuming no bound fraction. The quantity calculated is a posterior distribution of single values of s s and f b (or just s s )-(one distribution of each for nitrates, one of each for oxides) and a distribution of particle transport values for each of the 20 workers in each analysis. The distribution of s s and f b is jointly determined by all of the worker data. However, the distribution of particle transport parameter values obtained for each worker is only directly determined by the data for that particular worker. Particle transport parameter values can be obtained indirectly by the data from all of the workers through a correlation with s s and f b , of course, because the values of these parameters are jointly determined by the data from all workers in the analysis. More formally, posterior estimates of s s and f b are obtained from the marginal posterior distributions (the posterior probability distribution of values of a given parameter without reference to the values of other model parameters in the joint posterior probability distribution of all parameters), as follows:
The marginal distributions of s s and f b are distributions of single values that are described (determined) by all of the MPA data. However, L is a matrix of 20 × 4 parameters (intake and the three PTRs) and M is a 20 × 3 matrix of autopsy data (lung, LNTH and systemic burden) of 20 plutonium nitrate or oxide workers. Hence, integration of the right-hand side of Equation (2) or (3) (the joint posterior distribution of model parameters and intake conditioned on the data) can be used to obtain the marginal distribution of other parameters of interest in L, including the particle transport clearance parameters. These can be used to estimate posterior mean or median values, and other descriptors for these parameters.
Bayesian estimates of PTRs
Because, the PTRs are assumed to be unshared, the analysis produces a posterior estimate of each particle transport parameter for every worker included in the analysis (for example, there is a column of 20 values of the rate from alveolar region to bronchiolar region (ALV to bb) in the matrix L, one for each worker). The posterior distributions of these rates can be used to estimate a range for the geometric sample mean (GSM; assuming posterior distributions are lognormal) to validate the prior median values using the following rationale for any particular PTR:
(1) It is assumed that the lognormal distributions given in Table 1 accurately describe variability in the particle transport parameters. If the individual value for each worker could be determined with precision from the data (so that the posterior distribution of each rate is in effect a delta function), then the sampling distribution of the geometric mean for n = 20 workers, drawn randomly from the population of workers, also follows a lognormal distribution with median value of X, and GSD equal to exp[ln(T)/(20) 0.5 ], where X is the prior median value of the lognormal distribution describing variability in the population and T is the corresponding GSD given in Table 1 . This defines a 'null' distribution that can be used to test whether the posterior GSM derived from the n = 20 nitrate or n = 20 oxide cases is statistically significantly different from the null distribution. These null distributions are effectively 'prior' distributions for the GSM since they define what is known about this value (or equivalently, the population median) for a given sample of n = 20 workers before the additional bioassay data are considered.
(2) As far as the PTRs are concerned, the data are not particularly informative. Instead of a posterior distribution that is a delta function, the posterior estimate is uncertain. However, this uncertainty on the estimated value can be propagated into the estimated GSM, because each iteration of the MCMC algorithm samples a PTR for each worker that is informed by the worker's bioassay data and indirectly by the data of the other workers. This is a consequence of the fact that s s and f b are assumed to be shared values. A GSM can be calculated for any particular PTR from these n = 20 values as follows:
Each sampled GSM represents a 'plausible' GSM value that is consistent with the data. Consequently, the analysis produces a posterior distribution of GSMs that can be compared with the prior distribution of the GSM. If the two distributions overlap (the 95% range of values, for example), then this indicates that the true population median value is not statistically significantly different from X, the assumed prior median value. If the data are completely uninformative for the PTRs, then the posterior distribution of GSMs will be identical to the prior distribution of GSMs given in Table 1 (the 95% range of values will be coincident).
MCMC calculations
The analyses were performed using the MCMC method described by Puncher and Birchall (21) and Puncher et al. (22) The MCMC routines used the software IMBA Professional Plus (23) to calculate bioassay predictions. This MCMC method is an implementation of the single component Metropolis algorithm (24) . Briefly:
(1) For each analysis, two chains were initiated using different values of parameters with significant density in the posterior distribution. • The lung, LNTH and systemic data can be explained with or without including a permanent (shared) bound fraction as inferred from the posterior distributions of χ 2 alpha values; for example, 18-20 nitrate cases had posterior alpha values >0.05. This was observed whether a prior on f b was included in the analysis (binding is assumed to occur but its value is uncertain) or whether f b was fixed at zero (binding is assumed not to occur). This indicates that the observed lung:LNTH activity ratios can be explained without requiring a permanent bound fraction. This result is consistent with the histogram of f b given in Figure 1 , which was obtained from the MCMC output from the analysis of the 20 nitrate cases where the f b was allowed to vary. The histogram suggests a normal distribution lefttruncated at zero. The truncation corresponds to approximately the 25th percentile (the first quartile) of the same non-truncated normal distribution. This indicates that the likelihood of the data given f b = 0 has significant positive density.
RESULTS
Bayesian estimates of long-term binding
• The posterior distribution of f b for plutonium oxides suggests a much higher value than does the distribution determined from the plutonium nitrate data. The posterior median value for oxides is around a factor of 30 higher than the corresponding value determined from the nitrate cases. The higher result is a consequence of the fact that the range of f b values estimated from the oxide cases is much wider than determined for the nitrate cases-a consequence of the difference in solubility between the two materials (see 'Discussion' section).
• As was observed in the previous analysis of these cases by Puncher et al. (5) , posterior estimates of intakes were largely consistent with the levels of intake expected for these workers. The geometric mean ratio of posterior median/expected intake of 0.54 was observed for oxides and 1.1 for nitrates.
Bayesian estimates of PTRs
Posterior distributions of PTRs for individual workers were broad and lognormal with GSDs that were similar to their prior values. These results are consistent with the expectation that these data are generally uninformative for individual particle transport parameter values.
Posterior estimates of GSMs calculated for each PTR are given in Table 3 for the MCMC analyses that included a bound fraction. It was found that excluding binding (fixing f b at zero) had no discernible effect on the results. The posterior GSMs of the rates were approximately lognormal, consistent with the fact that the GSM of each distribution and its median value were almost in exact agreement. The geometric means of the distributions for each PTR, determined from two separate MCMC chains, were typically within 10% indicating that a reasonable level of convergence had been achieved. The results given in Table 3 are derived from the values of two combined chains. The main points of interest are
(1) The rate from the alveolar region to bronchiolar region (ALV to bb in Table 3 ): The posterior median values for nitrate and oxide appear to be higher than the prior median value, but similar to the ICRP (18) reference value of 0.002 d −1 . (2) The rate from the alveolar region to interstitial region (ALV to INT in Table 3 ): For both nitrate and oxide cases, the posterior median values are a factor of 2 (nitrates) or 5 (oxide) lower than the median value and the ICRP (18) reference value. (3) The rate from the interstitium to thoracic lymph nodes (INT to LNTH in Table 3 ): For oxide cases, the posterior median is comparable with the prior median and ICRP (18) reference value, of 0.00003 d −1 ; for nitrate cases, the median value is around 30% lower.
However, it is important to note that, with the exception of the ALV to INT rate for oxide cases, the 95% range of values overlaps the corresponding range of the prior distribution of the GSM. This suggests that for these rates the population median value for MPA workers is not statistically significantly different from the prior median value.
DISCUSSION
This work describes the application of Bayesian inference to determine whether the Mayak worker data used by Puncher et al. (5) (this series) to estimate values of the slow dissolution rate, s s , are also compatible with the hypothesis-supported by the analysis of USTUR Case 0269 (3) and Beagle lung data (4) -that long-term binding of plutonium occurs in the airways of the lung, and if so, derive values for the bound fraction, f b .
The results of the analysis indicate that the Mayak worker data (lung, LNTHs and systemic activity) are compatible with the existence of a small permanent bound fraction. However, it is also clear that the data do not provide any direct evidence for binding because they can also be explained by the model when the bound fraction is fixed at zero. It should be noted that these results do not contradict those obtained from the analysis of USTUR Case 0269 described by Puncher et al. (3) An analysis of the original autopsy data for that case by the present authors, which considered activity in the TB and AI regions together as a single 'lung measurement' as in the present analysis, showed that the lung:lymph activity ratio could be explained with or without assuming a permanent bound fraction, which is consistent with the results of this study. Only when new data became available showing that a significant proportion of this lung activity was actually in the tracheao-bronchial/bronchiolar region of USTUR Case 0269, rather than confined to the alveolar-interstitial region (as expected at such a late time after exposure), did it become apparent that a bound fraction >0 was required to explain it (3) . The results are also consistent with those obtained from the analysis of the Beagle dog data by Puncher et al. (4) ; this is because it was the combination of abundant early data (collected from time 0 up to 2000 days following exposure) and late data (collected beyond 2000 days post-exposure) in the Beagle dog study, which showed that a permanent bound fraction was required to explain the observed lung retention. As pointed out by Puncher et al. (5) , the Mayak data considered here consist only of late data (obtained beyond 2000 days post-exposure), which may be These are compared with prior distributions for the GSMs assuming the prior distributions representing variability on these parameters in Table 1. insufficient to demonstrate the requirement for a permanent bound fraction for these workers. Nevertheless, the posterior estimates of f b obtained from these data help to define a range of values. The posterior median f b value obtained from the analysis of MPA worker nitrate cases is around a factor of 30 lower than the corresponding value derived from the analysis of MPA worker oxide cases (0.14% versus 4.7%) ( Table 2) . This difference can easily be explained by the fact that the amount of plutonium that actually becomes bound is positively correlated with the rapid fraction f r and the rate of dissolution. Thus, the oxide dissolution parameters, which have a lower value of f r (0. Table 2 ). The fairly narrow range of low values is likely a consequence of the fact that there is a shallow but nevertheless clear downward trend in lung retention for these data, as apparent from plots of lung:systemic activity for the 20 nitrate workers described by Puncher et al. (5) This analysis, which considered lung and LNTH measurements separately, permits a closer look at the alveolar particle transport clearance rates. The broad posterior distributions observed for these rates indicate that the data are largely uninformative for them. This is not surprising since rates of particle transport clearance, being treated as unshared parameters, are only primarily informed by the (limited) data for each worker. Nevertheless, the derived distributions of the GSMs of these rates can at least be used to ascertain whether the population median values for MPA workers are consistent with the assumed prior median values. This provides reassurance that the prior median does not introduce 'bias' into the estimate of lung doses for these workers. With the exception of the ALV to INT rate for oxides, the distributions in Table 3 overlap with the prior, and thus there is no evidence to reject the 'null' hypothesis that the population median values are the same as their prior median values. The results are also broadly similar for nitrate and oxide cases, consistent with the assumption that mechanical particle transport clearance is not dependent on the chemical form of the inhaled material. Nevertheless, the results for the ALV to INT rate (Table 3) suggest that the population median value may be lower than the prior value, which is also the current HRTM reference value. However, strong conclusions cannot be drawn because the prior distribution assumed for this parameter approximates variability in this rate (19) . Furthermore, there is uncertainty on the prior median value itself, which was not included explicitly in the analysis. On that note, not incorporating this uncertainty-as a prior distribution on the median value for instancemeans that inference regarding the population median is treated somewhat in a Classical rather than Bayesian sense in this study. The definitive Bayesian approach is to use a hierarchical prior where variability in particle transport clearance is nested under uncertainty in the population median value, permitting the calculation of a posterior probability distribution of the population median (25) ; however, this approach was not possible with the non-hierarchical MCMC algorithm used in this analysis, which was built for the primary purpose of estimating values for the absorption parameters.
With regard to the particle transport clearance parameters, best agreement between prior and posterior is observed for the rate from the INT to LNTHs. This result is consistent with the fact that the geometric mean LNTH:lung concentration ratio for the sample of 20 nitrate and 20 oxide workers is 18 and 25, respectively, which is close to a value of 20 obtained from an analysis of autopsy data (nonsmokers) of USTUR donors exposed many years prior to death by Kathren et al. (20) and used to derive the HRTM (and prior median) value of 0.00003 d −1 for the rate from the INT to LNTH by Gregoratto et al. (19) The ratios observed for the sample of nitrate and oxide workers considered here appear to be representative of all MPA workers: a geometric mean of around 26 is observed for 481 sets of autopsy data from workers exposed to nitrates, oxides and mixtures (author's calculations). Of interest is the fact that the geometric dispersion of the LNTH:lung concentration ratios for these 481 sets of Mayak data is narrower than the range predicted by the prior distribution used in this study: the 95% range of values of the 481 cases is 2.1-248, versus 1.4-1300 for the prior (author's calculations). This suggests that inter-subject variation about the prior median value may be narrower than indicated by the prior GSD of three. However, strong conclusions cannot be drawn because this assessment is based on a simple analysis of [LNTH]:[Lung] activity ratios, and not a detailed biokinetic study of the entire Mayak autopsy dataset.
CONCLUSIONS
• The MPA worker lung, LNTH and systemic data can be explained with or without including binding. However, evidence for binding is presented in other papers (3, 4, 15) ; given that binding does occur then the Mayak data suggest a small bound fraction, f b , of between 0 and 0.3%.
• The data suggest that the population median values of the alveolar particle transport clearance parameters for MPA workers, particularly the rate from the INT to the LNTHs, are largely consistent with the prior median values. The results indicate that the rate from the alveolar region to the INT may be lower, but extending the analysis to consider a larger number of workers is required to confirm whether this result is statistically significant. 
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